Jensen J, Omar M, Moller JE, Schou M, et al. Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial". Am Heart J 2021;236:106.
PMID: 33902821